Noubar Afeyan
Director; Director, 10% Owner · 4 filings · Latest: May 21, 2026
Generate Biomedicines, Inc.
Moderna, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
MRNA | Noubar Afeyan | Director | May 21, 2026 | Sale | $46.84 | 9,263 | $433.9K | 3,924 | |
MRNA | Noubar Afeyan | Director | May 21, 2026 | Option Exercise | $19.15 | 9,263 | $177.4K | 13,187 | |
GENB | Noubar Afeyan | Director, 10% Owner | Mar 2, 2026 | Purchase | $16.00 | 4,687,500 | $75.0M | 1,562,500 | |
GENB | Noubar Afeyan | Director, 10% Owner | Mar 2, 2026 | Purchase | $16.00 | 4,687,500 | $75.0M | 1,562,500 |